After a bachelor of science in biology, Jean-Baptiste will graduate with a master’s degree in pharmacology of the Sorbone University (previously University Pierre et Marie Curie [UPMC]) in Paris.

He is currently focused on new therapies link to the intestinal microbiota. During his end-of-course internship, Jean-Baptiste will work on the development of a human microbiotia model in collaboration with the Pharmacology Lab of the university of Rennes 1 (INSERM U1230).

Welcome Jean-Baptiste !

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Could the microbiota be the solution to all our health problem? | HCS Pharma · March 29, 2018 at 10:00 am

[…] that can respond to their current needs. This research project is under going and realized by Jean-Baptiste Mascary who would develop human microbitota model in collaboration with the Pharmacology Lab of the […]

Jean-Baptiste joins our team as PhD student on an in vitro skin microbiota model topic | HCS Pharma · March 1, 2019 at 11:01 am

[…] his Master’s degree in Cellular and Molecular Biology at Paris-Sorbonne University in 2018 after a six-month internship with us. He focused on the development of a human microbiota model in collaboration with the Pharmacology […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.